Table of Contents
Chapter 1 Executive Summary
Chapter 2 Market Introduction
2.1 Definition
2.2 Scope of the Study
2.3 Assumptions and Limitations
2.4 Market Structure
Chapter 3 Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4 Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Detection Technique Trends & Assessment
Chapter 5 Market Factor Analysis
5.1 Porter’s Five Forces Analysis
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
5.2 Value Chain Analysis
5.3 Investment Feasibility Analysis
5.4 Pricing Analysis
Chapter 6 Global Immunoassay Market, by Product
6.1 Introduction
6.2 Reagents and Kits
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
6.3 Analyzers/Instruments
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
6.4 Software and Services
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
Chapter 7 Global Immunoassay Market, by Technology
7.1 Introduction
7.2 Radioimmunoassay (RIA)
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
7.3 Enzyme-linked Immunosorbent Assay (ELISA)
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
7.4 Enzyme-linked Fluorescent Assay (ELFA)
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
7.5 Chemiluminescence Immunoassay (CLIA)
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
7.6 Rapid Test
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
7.7 Others
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
Chapter 8 Global Immunoassay Market, by Indication
8.1 Introduction
8.2 Therapeutic Drug Monitoring
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
8.3 Oncology
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
8.4 Cardiology
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
8.5 Endocrinology
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
8.6 Infectious Diseases
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
8.7 Autoimmune Diseases
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
8.8 Others
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
Chapter 9 Global Immunoassay Market, by End User
9.1 Introduction
9.2 Hospitals
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
9.3 Clinical Laboratories
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
9.4 Blood Banks
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
9.5 Pharmaceutical and Biotechnology Companies
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
9.6 Academic and Research Institutes
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
9.7 Others
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
Chapter 10 Global Immunoassay Market, by Region
10.1 Introduction
10.2 Americas
10.2.1 North America
10.2.1.1 US
10.2.1.2 Canada
10.2.2 Latin America
10.3 Europe
10.3.1 Western Europe
10.3.1.1 Germany
10.3.1.2 France
10.3.1.3 Italy
10.3.1.4 Spain
10.3.1.5 UK
10.3.1.6 Rest of Western Europe
10.3.2 Eastern Europe
10.4 Asia-Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 South Korea
10.4.6 Rest of Asia-Pacific
10.5 Middle East & Africa
10.5.1 Middle East
10.5.2 Africa
Chapter 11 Company Landscape
11.1 Introduction
11.2 Market Share Analysis
11.3 Key Developments & Strategies
Chapter 12 Company Profiles
12.1 Thermo Fisher Scientific Inc.
12.1.1 Company Overview
12.1.2 Product Overview
12.1.3 Financial Overview
12.1.4 Key Developments
12.1.5 SWOT Analysis
12.1.6 Key Strategies
12.2 F. Hoffmann-La Roche Ltd
12.3 Siemens Healthineers
12.4 bioMérieux SA
12.5 Becton, Dickinson and Company
12.6 Danaher Corporation
12.7 Abbott Laboratories
12.8 Merck KGaA
12.9 Sysmex Corporation
12.10 Ortho Clinical Diagnostics/Carlyle Group
12.11 Quidel Corporation
12.12 DiaSorin S.p.A.
Chapter 13 MRFR Conclusion
13.1 Key Findings
13.1.1 From CEO’s Viewpoint
13.1.2 Unmet Needs of the Market
13.2 Key Companies to Watch
13.3 Predictions for the Immunoassay Industry
Chapter 14 Appendix
LIST OF TABLES
Table 1 Global Immunoassay Market Synopsis, 2020-2027
Table 2 Global Immunoassay Market Estimates and Forecast, 2020-2027 (USD Million)
Table 3 Global Immunoassay Market, by Region, 2020-2027 (USD Million)
Table 4 Global Immunoassay Market, by Product, 2020-2027 (USD Million)
Table 5 Global Immunoassay Market, by Technology, 2020-2027 (USD Million)
Table 6 Global Immunoassay Market, by Indication, 2020-2027 (USD Million)
Table 7 Global Immunoassay Market, by End User, 2020-2027 (USD Million)
Table 8 North America: Immunoassay Market, by Product, 2020-2027 (USD Million)
Table 9 North America: Immunoassay Market, by Technology, 2020-2027 (USD Million)
Table 10 North America Immunoassay Market, by Indication, 2020-2027 (USD Million)
Table 11 North America Immunoassay Market, by End User, 2020-2027 (USD Million)
Table 12 US: Immunoassay Market, by Product, 2020-2027 (USD Million)
Table 13 US: Immunoassay Market, by Technology, 2020-2027 (USD Million)
Table 14 US Immunoassay Market, by Indication, 2020-2027 (USD Million)
Table 15 US Immunoassay Market, by End User, 2020-2027 (USD Million)
Table 16 Canada: Immunoassay Market, by Product, 2020-2027 (USD Million)
Table 17 Canada: Immunoassay Market, by Technology, 2020-2027 (USD Million)
Table 18 Canada Immunoassay Market, by Indication, 2020-2027 (USD Million)
Table 19 Canada Immunoassay Market, by End User, 2020-2027 (USD Million)
Table 20 Latin America: Immunoassay Market, by Product, 2020-2027 (USD Million)
Table 21 Latin America: Immunoassay Market, by Technology, 2020-2027 (USD Million)
Table 22 Latin America Immunoassay Market, by Indication, 2020-2027 (USD Million)
Table 23 Latin America Immunoassay Market, by End User, 2020-2027 (USD Million)
Table 24 Europe: Immunoassay Market, by Product, 2020-2027 (USD Million)
Table 25 Europe: Immunoassay Market, by Technology, 2020-2027 (USD Million)
Table 26 Europe Immunoassay Market, by Indication, 2020-2027 (USD Million)
Table 27 Europe Immunoassay Market, by End User, 2020-2027 (USD Million)
Table 28 Western Europe: Immunoassay Market, by Product, 2020-2027 (USD Million)
Table 29 Western Europe: Immunoassay Market, by Technology, 2020-2027 (USD Million)
Table 30 Western Europe Immunoassay Market, by Indication, 2020-2027 (USD Million)
Table 31 Western Europe Immunoassay Market, by End User, 2020-2027 (USD Million)
Table 32 Eastern Europe: Immunoassay Market, by Product, 2020-2027 (USD Million)
Table 33 Eastern Europe: Immunoassay Market, by Technology, 2020-2027 (USD Million)
Table 34 Eastern Europe Immunoassay Market, by Indication, 2020-2027 (USD Million)
Table 35 Eastern Europe Immunoassay Market, by End User, 2020-2027 (USD Million)
Table 36 Asia-Pacific: Immunoassay Market, by Product, 2020-2027 (USD Million)
Table 37 Asia-Pacific: Immunoassay Market, by Technology, 2020-2027 (USD Million)
Table 38 Asia-Pacific Immunoassay Market, by Indication, 2020-2027 (USD Million)
Table 39 Asia-Pacific Immunoassay Market, by End User, 2020-2027 (USD Million)
Table 40 Middle East & Africa: Immunoassay Market, by Product, 2020-2027 (USD Million)
Table 41 Middle East & Africa: Immunoassay Market, by Technology, 2020-2027 (USD Million)
Table 42 Middle East & Africa Immunoassay Market, by Indication, 2020-2027 (USD Million)
Table 43 Middle East & Africa Immunoassay Market, by End User, 2020-2027 (USD Million)
LIST OF FIGURES
Figure 1 Research Process
Figure 2 Segmentation for Global Immunoassay Market
Figure 3 Segmentation Market Dynamics for Global Immunoassay Market
Figure 4 Global Immunoassay Market Share, by Product, 2020
Figure 5 Global Immunoassay Market Share, by Technology, 2020
Figure 6 Global Immunoassay Market Share, by Indication, 2020
Figure 7 Global Immunoassay Market Share, by End User, 2020
Figure 8 Global Immunoassay Market Share, by Region, 2020
Figure 9 North America: Immunoassay Market Share, by Country, 2020
Figure 10 Europe: Immunoassay Market Share, by Country, 2020
Figure 11 Asia-Pacific: Immunoassay Market Share, by Country, 2020
Figure 12 Middle East & Africa: Immunoassay Market Share, by Country, 2020
Figure 13 Global Immunoassay Market: Company Share Analysis, 2020 (%)
Figure 14 Thermo Fisher Scientific Inc.: Key Financials
Figure 15 Thermo Fisher Scientific Inc.: Segmental Revenue
Figure 16 Thermo Fisher Scientific Inc.: Geographical Revenue
Figure 17 F. Hoffmann-La Roche Ltd: Key Financials
Figure 18 F. Hoffmann-La Roche Ltd: Segmental Revenue
Figure 19 F. Hoffmann-La Roche Ltd: Geographical Revenue
Figure 20 Siemens Healthineers: Key Financials
Figure 21 Siemens Healthineers: Segmental Revenue
Figure 22 Siemens Healthineers: Geographical Revenue
Figure 23 bioMérieux SA: Key Financials
Figure 24 bioMérieux SA: Segmental Revenue
Figure 25 bioMérieux SA: Geographical Revenue
Figure 26 Becton, Dickinson and Company: Key Financials
Figure 27 Becton, Dickinson and Company: Segmental Revenue
Figure 28 Becton, Dickinson and Company: Geographical Revenue
Figure 29 Danaher Corporation: Key Financials
Figure 30 Danaher Corporation: Segmental Revenue
Figure 31 Danaher Corporation: Geographical Revenue
Figure 32 Abbott Laboratories: Key Financials
Figure 33 Abbott Laboratories: Segmental Revenue
Figure 34 Abbott Laboratories: Geographical Revenue
Figure 35 Merck KGaA: Key Financials
Figure 36 Merck KGaA: Segmental Revenue
Figure 37 Merck KGaA: Geographical Revenue
Figure 38 Sysmex Corporation: Key Financials
Figure 39 Sysmex Corporation: Segmental Revenue
Figure 40 Sysmex Corporation: Geographical Revenue
Figure 41 Ortho Clinical Diagnostics/Carlyle Group: Key Financials
Figure 42 Ortho Clinical Diagnostics/Carlyle Group: Segmental Revenue
Figure 43 Ortho Clinical Diagnostics/Carlyle Group: Geographical Revenue
Figure 44 Quidel Corporation: Key Financials
Figure 45 Quidel Corporation: Segmental Revenue
Figure 46 Quidel Corporation: Geographical Revenue
Figure 47 DiaSorin S.p.A.: Key Financials
Figure 48 DiaSorin S.p.A.: Segmental Revenue
Figure 49 DiaSorin S.p.A.: Geographical Revenue
